Skip to Content

WW 277 (Lithium 450 mg)

Pill imprint WW 277 has been identified as Lithium carbonate extended release 450 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; depression; cyclothymic disorder; intermittent explosive disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lithium carbonate extended release 450 mg WW 277
Lithium carbonate extended release 450 mg WW 277  Front
Lithium carbonate extended release 450 mg WW 277  Back
Lithium carbonate extended release
WW 277
450 mg
11.00 mm
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
West-Ward Pharmaceutical Corporation
National Drug Code (NDC):
Inactive Ingredients:
alginic acid
corn starch
magnesium stearate
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-6204 Major Pharmaceuticals
68084-0043 Amerisource Health Services
35356-0506 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.